The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada

This article identifies the potential sources of inequity in three stages of integrating cystic fibrosis personalized medicines into the Canadian healthcare system and proposes mitigating strategies: (1) clinical research and diagnostic testing; (2) regulatory oversight and market authorization; and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shemie, Genevieve, Nguyen, Minh Thu, Wallenburg, John, Ratjen, Felix, Knoppers, Bartha Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151662/
https://www.ncbi.nlm.nih.gov/pubmed/34067090
http://dx.doi.org/10.3390/jpm11050382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151662/
https://www.ncbi.nlm.nih.gov/pubmed/34067090
http://dx.doi.org/10.3390/jpm11050382

Ejemplares similares